Rituximab Maintenance Therapy for Autoimmune Pancreatitis

The dramatic response to steroids makes autoimmune pancreatitis (AIP) unique among pancreatic disorders. However, some cases are steroid-resistant, and relapse is common after steroid withdrawal. Mayo Clinic gastroenterologist Dr. Mark Topazian discusses a recent study which concludes that rituximab maintenance therapy can prolong remission. To learn more, visit mayocl.in/2Nz8cIz